Correlation Between Ascendis Pharma and Black Diamond

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and Black Diamond Therapeutics, you can compare the effects of market volatilities on Ascendis Pharma and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Black Diamond.

Diversification Opportunities for Ascendis Pharma and Black Diamond

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ascendis and Black is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Black Diamond go up and down completely randomly.

Pair Corralation between Ascendis Pharma and Black Diamond

Given the investment horizon of 90 days Ascendis Pharma AS is expected to under-perform the Black Diamond. But the stock apears to be less risky and, when comparing its historical volatility, Ascendis Pharma AS is 2.4 times less risky than Black Diamond. The stock trades about -0.11 of its potential returns per unit of risk. The Black Diamond Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  203.00  in Black Diamond Therapeutics on November 9, 2024 and sell it today you would earn a total of  49.00  from holding Black Diamond Therapeutics or generate 24.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Ascendis Pharma AS  vs.  Black Diamond Therapeutics

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ascendis Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Black Diamond Therap 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Ascendis Pharma and Black Diamond Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and Black Diamond

The main advantage of trading using opposite Ascendis Pharma and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.
The idea behind Ascendis Pharma AS and Black Diamond Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated